Globus Medical (GMED) Cash from Operations (2011 - 2026)

Globus Medical (GMED) has reported Cash from Operations for 16 consecutive years, with $209.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations rose 169.36% year-over-year to $209.7 million; the trailing twelve-month figure through Jun 2026 stood at $910.4 million (up 36.05% YoY), and the FY2025 full-year result was $753.4 million, up 44.72% from the prior year.
• Cash from Operations improved to $209.7 million in Q2 2026 per GMED's latest filing, from $202.4 million in the prior quarter.
• Across five years, Cash from Operations topped out at $249.7 million in Q3 2025 and bottomed at $32.9 million in Q3 2022.
• Historically, Cash from Operations has averaged $117.1 million across 5 years, with a median of $70.9 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Cash from Operations sank 57.39% in 2022, then soared 303.4% in 2024.
• Over 5 years, Cash from Operations stood at $64.0 million in 2022, then surged by 63.62% to $104.7 million in 2023, then surged by 100.95% to $210.3 million in 2024, then increased by 18.18% to $248.6 million in 2025, then dropped by 15.63% to $209.7 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered $209.7 million, $202.4 million, and $248.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.